Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
36.4M
-
Shares change
-
-3.45M
-
Total reported value, excl. options
-
$36.8M
-
Value change
-
-$7.77M
-
Put/Call ratio
-
0.15
-
Number of buys
-
41
-
Number of sells
-
-19
-
Price
-
$1.01
Significant Holders of Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) as of Q4 2024
81 filings reported holding IPSC - Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Century Therapeutics, Inc. - Common Stock, $0.0001 par value per share (IPSC) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.4M shares
of 86.3M outstanding shares and own 42.17% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (5.41M shares), Casdin Capital, LLC (5.19M shares), VR Adviser, LLC (3.96M shares), BlackRock, Inc. (3.04M shares), FMR LLC (2.53M shares), VANGUARD GROUP INC (2.38M shares), DAFNA Capital Management LLC (1.7M shares), MILLENNIUM MANAGEMENT LLC (1.61M shares), Syncona Portfolio Ltd (1.21M shares), and RENAISSANCE TECHNOLOGIES LLC (1.2M shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.